A 14-study meta-analysis found GLP-1 receptor agonists -- especially semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, ...
GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating how this dual effect impacts health. Anti-obesity drugs such as semaglutide (Ozempic, Wegovy), are ...
A Yale study finds GLP-1 drugs like Ozempic and Wegovy may slow alcohol breakdown, raising blood alcohol levels even as they ...
Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new research led by Christian ...
New research suggests GLP-1 weight-loss drugs like Ozempic and Zepbound may reduce cravings for alcohol and drugs by ...
Compared with DPP4i, use of semaglutide, tirzepatide, and liraglutide were associated with lower incidence of alcohol use disorder among patients with type 2 diabetes. Tirzepatide, semaglutide, and ...
Some doctors are prescribing weight-loss drugs such as Zepbound and Ozempic to help reduce cravings for illicit drugs and ...
Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...
2/20/25 (LAPost.com) — New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption. The study, published in JAMA ...
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical ...
This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...